Skip to main content

Sanofi COVID-19 vaccine to cost below €10 and drug ingredients IPO planned within months, its France chief says

Sanofi stock rose on Monday, as a senior executive said its drugs ingredients IPO was planned for the coming months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.